Bayer Rapid Relief

Product NDC: 0280-0103
11-digit product format: 002800103
Labeler code: 0280
Product ID: 0280-0103_45372de8-2f8f-007c-e063-6294a90a4f7b
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin/Caffeine Oral Powder
Dosage form: POWDER
Route: ORAL
Labeler: Bayer HealthCare LLC.
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2023-01-13
Substance: CAFFEINE; ASPIRIN
Active strength: 65; 650 mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 22 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	0280-0103-04	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	0280-0103-04	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	0280-0103-04	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	0280-0103-04	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	0280-0103-04	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	0280-0103-04	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	0280-0103-04	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	0280-0103-04	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	0280-0103-04	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	0280-0103-04	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	0280-0103-04	`27f29a85d7e4…`	`1372111e901f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Bayer Rapid Relief
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CAFFEINE	65 mg/1
ASPIRIN	650 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3G6A5W338E	Internal UNII lookup
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2626726	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f1fecbb0-5b55-fe8f-e053-2995a90a0977	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0280-0103-01	Bayer Rapid Relief	10 in 1 PACKET	POWDER	10	10
0280-0103-01	Bayer Rapid Relief	1 in 1 CARTON	POWDER	1	10
0280-0103-02	Bayer Rapid Relief	1 in 1 CARTON	POWDER	1	10
0280-0103-02	Bayer Rapid Relief	20 in 1 PACKET	POWDER	20	10
0280-0103-03	Bayer Rapid Relief	1 in 1 CARTON	POWDER	1	10
0280-0103-03	Bayer Rapid Relief	30 in 1 PACKET	POWDER	30	10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0280-0103-01	EA - Each	0280-0103	d9b59d60-ff18-4c1a-aa0d-b8d47e998a51	1	2025-05-14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0280-0103	BAYER RAPID RELIEF (ASPIRIN/CAFFEINE ORAL POWDER) POWDER [BAYER HEALTHCARE LLC.]	8	Current NDC, 6 package rows	20241208_f1fecbb0-5b55-fe8f-e053-2995a90a0977.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 32 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Low Dose Aspiriun	ASPIRIN	AMERIFOODS TRADING COMPANY	3802c96a-5e2a-ba9c-e063-6394a90abb78	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227aeb1-dd2c-9ca1-e063-6294a90ad709	2025-11-20	Warnings	Exact identifier application number: M013
good sense pain relief	ACETAMINOPHEN	NuCare Pharamceuticals, Inc.	440c13d7-edf0-f611-e063-6394a90af995	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227a2cc-69fa-869d-e063-6294a90a1d41	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	422796ed-7558-f7e8-e063-6294a90ad1c7	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	3e61abe4-b4be-01af-e063-6394a90a8b24	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	HYVEE INC	3e60703b-a5cf-333a-e063-6394a90a2087	2025-11-20	Warnings	Exact identifier application number: M013
ASPIRIN	ASPIRIN	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	54e4ae54-caf8-4105-8428-256f56a2f68f	2025-11-19	Warnings	Exact identifier application number: M013
MIDOL COMPLETE	ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE	R J General Corporation	0c09a178-1a07-4079-b4a6-d1657cb8e714	2025-11-17	Warnings	Exact identifier application number: M013
Alka-Seltzer Original	ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE	R J General Corporation	dbb0d067-71f0-45e4-bc98-548cf4a90b3a	2025-11-17	Warnings	Exact identifier application number: M013
MOTRIN IB	IBUPROFEN	R J General Corporation	afa87bb5-7fcb-4ccd-acac-f7931242181f	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	99e45e83-37a3-44df-9a2a-98ba7457a5bb	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL PM EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	a40ea0e3-d666-4605-b5e0-beeaf8f586f2	2025-11-17	Warnings	Exact identifier application number: M013
Acetaminophen 250 mg and Ibuprofen 125 mg	ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG	R J General Corporation	68d3be55-9340-4cc9-a05a-12b9338ddc56	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	dd9aaf80-6c2b-41a3-87b9-61642aaed4f0	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c18a2da-1718-4c00-aea8-9fb4a3418312	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	cd3060a5-3b90-42e4-89cd-3b620859045f	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c7221ae-52d1-4d18-b586-c47ff656150d	2025-11-17	Warnings	Exact identifier application number: M013
Excedrin Extra Strength Headache	ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE	R J General Corporation	907c89e7-2482-465f-9f85-2381ecab1b86	2025-11-17	Warnings	Exact identifier application number: M013
Bayer Genuine Aspirin	ASPIRIN	R J General Corporation	23daa359-d40f-4f64-81be-6d154f41df9f	2025-11-17	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2626726	aspirin 650 MG / caffeine 65 MG Oral Powder	PSN	f1fecbb0-5b55-fe8f-e053-2995a90a0977	10
2626726	aspirin 650 MG / caffeine 65 MG Oral Powder	SCD	f1fecbb0-5b55-fe8f-e053-2995a90a0977	10
2626726	ASA 650 MG / caffeine 65 MG Oral Powder	SY	f1fecbb0-5b55-fe8f-e053-2995a90a0977	10

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
0280-0103-01	00280010301	1 PACKET in 1 CARTON (0280-0103-01) / 10 POWDER in 1 PACKET	1 packet	2023-01-13	No	No	Current
0280-0103-02	00280010302	1 PACKET in 1 CARTON (0280-0103-02) / 20 POWDER in 1 PACKET	1 packet	2023-01-13	No	No	Current
0280-0103-03	00280010303	1 PACKET in 1 CARTON (0280-0103-03) / 30 POWDER in 1 PACKET	1 packet	2023-01-13	No	No	Current